Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marzia Santamaria"'
Autor:
Francesca Ligorio, Luca Zambelli, Giovanni Fucà, Riccardo Lobefaro, Marzia Santamaria, Emma Zattarin, Filippo de Braud, Claudio Vernieri
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Human Epidermal growth factor Receptor 2 (HER2) overexpression or HER2 gene amplification defines a subset of breast cancers (BCs) characterized by higher biological and clinical aggressiveness. The introduction of anti-HER2 drugs has remarkably impr
Externí odkaz:
https://doaj.org/article/9e73ed9583ae4cee885a74db768a4b79
Autor:
Maila Becconi, Simona De Zio, Francesco Falciani, Marzia Santamaria, Marco Malferrari, Stefania Rapino
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1327
Volume 15
Issue 4
Pages: 1327
Current cancer research is limited by the availability of reliable in vivo and in vitro models that are able to reproduce the fundamental hallmarks of cancer. Animal experimentation is of paramount importance in the progress of research, but it is be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf0dfae0b2e96a60cbeed10a198a84ba
https://doi.org/10.3390/cancers15041327
https://doi.org/10.3390/cancers15041327
Autor:
Emma Zattarin, Filippo de Braud, Riccardo Lobefaro, Lorenzo Castagnoli, Francesca Ligorio, Marzia Santamaria, Claudio Vernieri, Andrea Vingiani, Ilaria Pellegrini, Serenella M. Pupa, Giancarlo Pruneri
Publikováno v:
Cancer letters. 511
De novo or acquired resistance of cancer cells to currently available Human Epidermal Growth Factor Receptor 2 (HER2) inhibitors represents a clinical challenge. Several resistance mechanisms have been identified in recent years, with lipid metabolis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6810f357eef60c065815361c3406877
https://pubmed.ncbi.nlm.nih.gov/33961924
https://pubmed.ncbi.nlm.nih.gov/33961924